B

Brainsway Ltd
NASDAQ:BWAY

Watchlist Manager
Brainsway Ltd
NASDAQ:BWAY
Watchlist
Price: 13.22 USD 0.92% Market Closed
Market Cap: 224.7m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

BWAY Price Targets Summary
Brainsway Ltd

There are no price targets for BWAY.
BWAY Lowest Forecast
Wall Street Target
Not Available
BWAY Average Forecast
Wall Street Target
Not Available
BWAY Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Brainsway Ltd Competitors:
Price Targets
NPCE
Neuropace Inc
65% Upside
NVCR
Novocure Ltd
89% Upside
MOVE
Medacta Group SA
16% Upside
NNOX
Nano-X Imaging Ltd
95% Upside
NPCE
Neuropace Inc
65% Upside
NVCR
Novocure Ltd
89% Upside
MOVE
Medacta Group SA
16% Upside
NNOX
Nano-X Imaging Ltd
95% Upside
M
305090
Micro Digital Co Ltd
110% Upside
145720
Dentium Co Ltd
42% Upside
BDX
Becton Dickinson and Co
29% Upside
GMED
Globus Medical Inc
50% Upside

Revenue
Forecast

Revenue Estimate
Brainsway Ltd

For the last 13 years the compound annual growth rate for Brainsway Ltd's revenue is 47%. The projected CAGR for the next 2 years is 135%.

47%
Past Growth
135%
Estimated Growth
Estimates Accuracy
-74%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Brainsway Ltd

The compound annual growth rate of Brainsway Ltd's operating income for the next 2 years is 290%.

N/A
Past Growth
290%
Estimated Growth
Estimates Accuracy
-77%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Brainsway Ltd

The compound annual growth rate of Brainsway Ltd's net income for the next 2 years is 71%.

N/A
Past Growth
71%
Estimated Growth
Estimates Accuracy
-53%
Average Miss
What are analyst estimates?

See Also

Summary
BWAY intrinsic value, competitors valuation, and company profile.
DCF Valuation
BWAY stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BWAY stock valuation using valuation multiples.
Wall Street Estimates
BWAY price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BWAY stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BWAY's stock price target?
Not Available

BWAY doesn't have any price targets made by Wall Street professionals.

What is Brainsway Ltd's Revenue forecast?
Projected CAGR
135%

For the last 13 years the compound annual growth rate for Brainsway Ltd's revenue is 47%. The projected CAGR for the next 2 years is 135%.

What is Brainsway Ltd's Operating Income forecast?
Projected CAGR
290%

The compound annual growth rate of Brainsway Ltd's operating income for the next 2 years is 290%.

What is Brainsway Ltd's Net Income forecast?
Projected CAGR
71%

The compound annual growth rate of Brainsway Ltd's net income for the next 2 years is 71%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 264,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.